Sorafenib and quinacrine target anti-apoptotic protein MCL1: A poor prognostic marker in Anaplastic Thyroid Cancer (ATC)

Junaid Abdulghani, Prashanth Gokare, Jean Nicolas Gallant, David Dicker, Tiffany Whitcomb, Timothy Cooper, Jiangang Liao, Jonathan Derr, Jing Liu, David Goldenberg, Niklas K. Finnberg, Wafik S. El-Deiry

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib and quinacrine target anti-apoptotic protein MCL1: A poor prognostic marker in Anaplastic Thyroid Cancer (ATC)'. Together they form a unique fingerprint.

Medicine & Life Sciences